![Targeting Disease Progression in Crohn's Disease: Fighting an Unrelenting Enemy - European Medical Journal Targeting Disease Progression in Crohn's Disease: Fighting an Unrelenting Enemy - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2018/01/New-Website-Photographs-.8-940x564.jpg)
Targeting Disease Progression in Crohn's Disease: Fighting an Unrelenting Enemy - European Medical Journal
![A Vall d'Hebron project receives the N-ECCO grant awarded by the European Crohn's and Ulcerative Colitis Organization | Vall d'Hebron Barcelona Hospital Campus A Vall d'Hebron project receives the N-ECCO grant awarded by the European Crohn's and Ulcerative Colitis Organization | Vall d'Hebron Barcelona Hospital Campus](https://www.vallhebron.com/sites/default/files/styles/crop_16_9_large/public/2023-03/guanyadors-ecco-2023.jpg?itok=CG8dlAsd)
A Vall d'Hebron project receives the N-ECCO grant awarded by the European Crohn's and Ulcerative Colitis Organization | Vall d'Hebron Barcelona Hospital Campus
![Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease | SpringerLink Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10620-019-06036-0/MediaObjects/10620_2019_6036_Fig1_HTML.png)
Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease | SpringerLink
![Y-ECCO on Twitter: "Our ECCO President @Julian Panes updates the @my_ueg #IBD community on the use of MSCs - results of the ASTIC study #Uegweek # ECCO-IBD https://t.co/gPB4lrFjeu" / Twitter Y-ECCO on Twitter: "Our ECCO President @Julian Panes updates the @my_ueg #IBD community on the use of MSCs - results of the ASTIC study #Uegweek # ECCO-IBD https://t.co/gPB4lrFjeu" / Twitter](https://pbs.twimg.com/media/DNiORUyXcAAa_5u.jpg)
Y-ECCO on Twitter: "Our ECCO President @Julian Panes updates the @my_ueg #IBD community on the use of MSCs - results of the ASTIC study #Uegweek # ECCO-IBD https://t.co/gPB4lrFjeu" / Twitter
![PDF) P744 Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): Results from the nationwide EpidemIBD study of GETECCU PDF) P744 Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): Results from the nationwide EpidemIBD study of GETECCU](https://i1.rgstatic.net/publication/338651044_P744_Epidemiology_clinical_characteristics_evolution_and_treatments_in_newly_diagnosed_inflammatory_bowel_disease_IBD_Results_from_the_nationwide_EpidemIBD_study_of_GETECCU/links/60c086ada6fdcc512816e3e5/largepreview.png)
PDF) P744 Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): Results from the nationwide EpidemIBD study of GETECCU
![Y-ECCO on Twitter: "Our ECCO President @Julian Panes updates the @my_ueg #IBD community on the use of MSCs - results of the ASTIC study #Uegweek # ECCO-IBD https://t.co/gPB4lrFjeu" / Twitter Y-ECCO on Twitter: "Our ECCO President @Julian Panes updates the @my_ueg #IBD community on the use of MSCs - results of the ASTIC study #Uegweek # ECCO-IBD https://t.co/gPB4lrFjeu" / Twitter](https://pbs.twimg.com/media/DNiORUyX0AESU9T.jpg)
Y-ECCO on Twitter: "Our ECCO President @Julian Panes updates the @my_ueg #IBD community on the use of MSCs - results of the ASTIC study #Uegweek # ECCO-IBD https://t.co/gPB4lrFjeu" / Twitter
![Ladri 5,20 cappuccino e scontrino non fiscale - Picture of Restaurant Bar Picasso, Barcelona - Tripadvisor Ladri 5,20 cappuccino e scontrino non fiscale - Picture of Restaurant Bar Picasso, Barcelona - Tripadvisor](https://media-cdn.tripadvisor.com/media/photo-s/11/a8/d4/39/ecco-qua-lo-scontrino.jpg)